VyncaCare is a technology company.
VyncaCare has raised $30.0M across 1 funding round.
VyncaCare has raised $30.0M in total across 1 funding round.
VyncaCare has raised $30.0M in total across 1 funding round.
VyncaCare's investors include Autism Impact Fund, Deerfield Management, Questa Capital.
VyncaCare is a health technology company that delivers person-centered palliative care and serious illness management through a hybrid model of in-home visits, virtual support, and AI-powered software. It serves patients with life-limiting illnesses, their families, healthcare providers, and payers by solving gaps in advance care planning, symptom management, and care coordination to enable more quality days at home and reduce avoidable hospitalizations.[1][2][4] Originally focused on advance care planning software, VyncaCare has grown into a comprehensive provider, operating in multiple U.S. states with predictive tech that monitors patient data for early interventions; it has raised over $40 million in funding and continues expanding geographically.[1][3]
VyncaCare originated in 2013 when it was founded in Palo Alto, California, by clinicians including co-founder Ryan Van Wert, M.D., with a vision to simplify advance care planning for seriously ill patients through digital software for creating, storing, and sharing goals-of-care documents integrated into electronic medical records.[1][2][3] The idea emerged from observing inconsistencies in end-of-life care wishes, leading to nationwide adoption by hospitals and clinics serving millions.[1] A pivotal shift occurred in 2021 with the acquisition of ReSolutionCare—a virtual-first palliative care practice founded in 2014 by Michael Fratkin, M.D., in Northern California—prompting expansion into direct clinical services.[1][3] The company rebranded to VyncaCare in 2022 to reflect its hybrid care model, began serving Oregon, Washington, Utah, and Idaho that year, and appointed Darren Schulte, M.D., as CEO in 2023, succeeding Van Wert, amid further growth into four western states.[1][3]
VyncaCare stands out in palliative care through its integrated tech-clinical model:
VyncaCare rides the wave of value-based care and home health expansion, addressing palliative shortages amid aging populations and rising chronic illness costs, where traditional models fail to deliver longitudinal, proactive support.[1][3][5] Timing aligns with post-pandemic telehealth acceleration and AI adoption in healthcare, enabling scalable interventions that cut ER/hospital use—key as payers prioritize outcomes over volume.[2][5] Market forces like Medicare Advantage growth and serious illness prevalence favor its model, influencing the ecosystem by pioneering AI-orchestrated palliative tech that integrates with EHRs and sets standards for hybrid, person-centered care beyond acute settings.[3][5][7]
VyncaCare is poised for rapid scaling, targeting 5-7 additional southern and midwestern states within the next year via its tech-driven model, with AI agents automating admin tasks to boost clinician efficiency.[1][5] Trends like predictive analytics maturation and payer demands for de-escalation will propel growth, potentially deepening partnerships with risk-bearing entities. Its influence may evolve from software pioneer to national palliative leader, redefining serious illness care for sustained quality-of-life gains—echoing its founding mission of wish-aligned, home-based support.[1][3][5]
VyncaCare has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series C in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2022 | $30.0M Series C | Autism Impact Fund, Deerfield Management, Questa Capital |